+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Liver Diseases Treatment - Global Strategic Business Report - Product Thumbnail Image

Liver Diseases Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 194 Pages
  • Global
From
From
Fatty Liver Treatment - Global Strategic Business Report - Product Thumbnail Image

Fatty Liver Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 285 Pages
  • Global
From
Ibuprofen Arginine API Market - Global Forecast to 2030 - Product Thumbnail Image

Ibuprofen Arginine API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
HIV-related Lymphoma Drug Market - Global Forecast 2025-2030 - Product Thumbnail Image

HIV-related Lymphoma Drug Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
From
From
HIV Drugs Market 2024-2028 - Product Thumbnail Image

HIV Drugs Market 2024-2028

  • Report
  • July 2024
  • 164 Pages
  • Global
From
HIV Treatment Drugs Market in Africa 2024-2028 - Product Thumbnail Image

HIV Treatment Drugs Market in Africa 2024-2028

  • Report
  • July 2024
  • 162 Pages
  • Africa
From
Immuno-Oncology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Immuno-Oncology Clinical Trials Market Report 2023-2033

  • Report
  • September 2023
  • 249 Pages
  • Global
From
From
HIV Clinical Trials Market - Global Forecast 2025-2030 - Product Thumbnail Image

HIV Clinical Trials Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
From
Loading Indicator